FibroGen Inc (FGEN)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

FibroGen Inc (FGEN)-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH13844D
  • |
  • Pages: 35
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

FibroGen Inc (FibroGen) is a biotechnology company that discovers, develops and commercializes new therapeutics. The company's pipeline product portfolio includes FG-4592, an oral small molecule inhibitor of HIF prolyl hydroxylases that is used for the treatment of anemia in chronic kidney disease; FG-3019, a monoclonal antibody developed to treat duchenne muscular dystrophy, idiopathic pulmonary fibrosis, pancreatic cancer, and liver fibrosis. Its roxadustat is supported by extensive clinical data demonstrating correction and maintenance of hemoglobin levels in multiple subpopulations of CKD anemia patients. The company conducts research and development in the fields of connective tissue growth factor and hypoxia-inducible factor. FibroGen is headquartered in San Francisco, California, the US.

FibroGen Inc (FGEN)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents

List of Tables

List of Figures

FibroGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018

FibroGen Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018

FibroGen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018

FibroGen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018

FibroGen Inc, Medical Devices Deals, 2012 to YTD 2018

FibroGen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018

FibroGen Inc, Pharmaceuticals & Healthcare, Deal Details

Partnerships

AstraZeneca Enters Into Co-Development Agreement With FibroGen For FG-4592

Equity Offering

FibroGen Prices Public Offering of Shares for USD326 Million

FibroGen Raises USD120 Million in Public Offering of Shares

FibroGen Raises USD168 Million in IPO of Shares

FibroGen to Raise USD20 Million in Private Placement of Shares

FibroGen Inc-Key Competitors

FibroGen Inc-Key Employees

FibroGen Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Recent Developments

Financial Announcements

Feb 27, 2018: FibroGen Announces Fourth Quarter and Full Year 2017 Financial Results

Nov 08, 2017: FibroGen Reports Third Quarter 2017 Financial Results

Aug 07, 2017: FibroGen Reports Second Quarter 2017 Financial Results

May 09, 2017: FibroGen Reports First Quarter 2017 Financial Results

Mar 01, 2017: FibroGen Reports Fiscal 2016 Financial Results

Corporate Communications

Sep 19, 2017: FibroGen Appoints Gerald Lema to Board of Directors

Product News

03/31/2017: FibroGen Announces China FDA Approval of CTA to Conduct Pivotal Phase 2/3 Clinical Trial of Roxadustat in Anemia Associated With Lower Risk MDS

Clinical Trials

Mar 30, 2017: Positive Results Published in Nephrology Dialysis Transplantation From Two China Phase 2 Trials of Roxadustat for Treatment of Anemia in Chronic Kidney Disease

Jan 30, 2017: FibroGens Roxadustat (FG-4592) Meets Primary Endpoints in Two Phase 3 Anemia Studies in China

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer

List of Figures

FibroGen Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

FibroGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018

FibroGen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018

FibroGen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018

FibroGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018

FibroGen Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

FibroGen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018

FibroGen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018

FibroGen Inc, Medical Devices Deals, 2012 to YTD 2018

List of Tables

FibroGen Inc, Pharmaceuticals & Healthcare, Key Facts, 2016

FibroGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018

FibroGen Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018

FibroGen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018

FibroGen Inc, Deals By Therapy Area, 2012 to YTD 2018

FibroGen Inc, Medical Devices Deals, 2012 to YTD 2018

FibroGen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018

AstraZeneca Enters Into Co-Development Agreement With FibroGen For FG-4592

FibroGen Prices Public Offering of Shares for USD326 Million

FibroGen Raises USD120 Million in Public Offering of Shares

FibroGen Raises USD168 Million in IPO of Shares

FibroGen to Raise USD20 Million in Private Placement of Shares

FibroGen Inc, Key Competitors

FibroGen Inc, Key Employees

FibroGen Inc, Subsidiaries

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

select a license

Single User License
USD 250 INR 16998
Site License
USD 500 INR 33995
Corporate User License
USD 750 INR 50993

NEWSLETTER BY CATEGORY




Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com